Sattar, Naveed
Article History
Received: 5 February 2019
Accepted: 5 February 2019
First Online: 26 February 2019
Authors’ information
: NS is a clinical academic, clinically active, with wide experience in diabetes epidemiology, biomarkers, guidelines and clinical trials. He has written over 700 peer reviewed papers and is among the most widely cited academics in the world.
: Not applicable.
: Not applicable.
: NS has consulted for AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, NAPP Pharmaceuticals, Novo Nordisk and Sanofi and has received a grant from Boehringer Ingelheim for conduct of a clinical trial.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.